531042 | Estrogen Receptor Antagonist, ICI 182,780 - CAS 129453-61-8 - Calbiochem

531042
価格が見つかりません
Minimum Quantity needs to be mulitiple of
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      価格&在庫状況を照会
      クリックして印刷用に表示

      概要

      Replacement Information

      主要スペック表

      Empirical FormulaCAS #
      C₃₂H₄₇F₅O₃S 129453-61-8

      価格&在庫状況

      カタログ番号在庫状況 包装 Qty/Pk 価格 数量
      5.31042.0001
      在庫状況検索中…
      現在国内在庫なし現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください

          ガラスビン 10 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          Description
          OverviewA cell-permeable estradiol derivative that acts as an estrogen antagonist and down-regulates estrogen receptors without affecting estrogen receptor-mediated progesterone receptor expression. Hence, it lacks estrogen agonist activity. Shown to be more effective than tamoxifen in reducing estrogen receptors in breast tumor cells. Suppresses the growth of MCF-7 xenografts in mice for twice as long as tamoxifen and delays tumor growth.

          Please note that the molecular weight for this compound is batch-specific due to variable water content.
          Catalogue Number531042
          Brand Family Calbiochem®
          SynonymsGPR30 Agonist, ICI 182,780, ICI 182780, ICI182780
          References
          ReferencesWakeling, A. E., et al. 1991. Cancer Res. 51, 3867.
          Dauvois, S., et al. 1993. J. Cell. Sci. 106, 1377.
          Howell, A., et al. 1995. The Lancet. 8941, 29.
          Robertson, J.F., et al. 2001. J. Steroid Biochem. Mol Biol. 79, 209.
          Product Information
          CAS number129453-61-8
          DeclarationSold with the permission of AstraZeneca UK. Limited for research purposes only.
          FormWhite powder
          Hill FormulaC₃₂H₄₇F₅O₃S
          Chemical formulaC₃₂H₄₇F₅O₃S
          ReversibleY
          Applications
          Biological Information
          Primary TargetER
          Secondary targetGPR30
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          (M)SDS

          タイトル

          英語版製品安全データシート((M)SDS) 

          参考資料

          参考資料の概要
          Wakeling, A. E., et al. 1991. Cancer Res. 51, 3867.
          Dauvois, S., et al. 1993. J. Cell. Sci. 106, 1377.
          Howell, A., et al. 1995. The Lancet. 8941, 29.
          Robertson, J.F., et al. 2001. J. Steroid Biochem. Mol Biol. 79, 209.
          データシート

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision29-August-2014 JSW
          SynonymsGPR30 Agonist, ICI 182,780, ICI 182780, ICI182780
          DescriptionA cell-permeable estradiol derivative that acts as an estrogen antagonist and down-regulates estrogen receptors without affecting estrogen receptor-mediated progesterone receptor expression. Hence, it lacks estrogen agonist activity. Shown to be more effective than tamoxifen in reducing estrogen receptors in breast tumor cells. Suppresses the growth of MCF-7 xenografts in mice for twice as long as tamoxifen and delays tumor growth.

          Please note that the molecular weight for this compound is batch-specific due to variable water content.
          FormWhite powder
          Intert gas (Yes/No) Packaged under inert gas
          CAS number129453-61-8
          Chemical formulaC₃₂H₄₇F₅O₃S
          Purity≥98% by HPLC
          SolubilityDMSO (100 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Standard Handling
          ReferencesWakeling, A. E., et al. 1991. Cancer Res. 51, 3867.
          Dauvois, S., et al. 1993. J. Cell. Sci. 106, 1377.
          Howell, A., et al. 1995. The Lancet. 8941, 29.
          Robertson, J.F., et al. 2001. J. Steroid Biochem. Mol Biol. 79, 209.